SUMAVEL DOSEPRO (sumatriptan succinate)
Endo operations
Patent: 8,287,489
Expiration: Dec 6, 2024
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com